Literature DB >> 26914930

A novel GFAP mutation in a type II (late-onset) Alexander disease patient.

Anderson Rodrigues Brandão de Paiva1, Fernando Freua2, Leandro Tavares Lucato3, Jacy Parmera2, Denise Dória2, Paulo Ribeiro Nóbrega2, Thiago Rosa Olávio4, Lúcia Inês Macedo-Souza4, Fernando Kok2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26914930     DOI： 10.1007/s00415-016-8065-8

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  4 in total

1.  Chronic stage of Marchiafava-Bignami disease.

Authors:  Leandro Tavares Lucato; Fernando Freua; Fernando Kok
Journal:  Arq Neuropsiquiatr       Date:  2015-08-11       Impact factor: 1.420

2.  Imaging of adult leukodystrophies.

Authors:  Claudia Costa Leite; Leandro Tavares Lucato; Germana Titoneli Santos; Fernando Kok; Anderson Rodrigues Brandão; Mauricio Castillo
Journal:  Arq Neuropsiquiatr       Date:  2014-08       Impact factor: 1.420

3.  Neuroimaging and clinical features in type II (late-onset) Alexander disease.

Authors:  Jonathan Graff-Radford; Kara Schwartz; Ralitza H Gavrilova; Daniel H Lachance; Neeraj Kumar
Journal:  Neurology       Date:  2013-12-04       Impact factor: 9.910

4.  GFAP mutations, age at onset, and clinical subtypes in Alexander disease.

Authors:  M Prust; J Wang; H Morizono; A Messing; M Brenner; E Gordon; T Hartka; A Sokohl; R Schiffmann; H Gordish-Dressman; R Albin; H Amartino; K Brockman; A Dinopoulos; M T Dotti; D Fain; R Fernandez; J Ferreira; J Fleming; D Gill; M Griebel; H Heilstedt; P Kaplan; D Lewis; M Nakagawa; R Pedersen; A Reddy; Y Sawaishi; M Schneider; E Sherr; Y Takiyama; K Wakabayashi; J R Gorospe; A Vanderver
Journal:  Neurology       Date:  2011-09-14       Impact factor: 11.800
  4 in total
  1 in total

Review 1.  Identification of a novel de novo pathogenic variant in GFAP in an Iranian family with Alexander disease by whole-exome sequencing.

Authors:  Katayoun Heshmatzad; Niloofar Naderi; Tannaz Masoumi; Hamidreza Pouraliakbar; Samira Kalayinia
Journal:  Eur J Med Res       Date:  2022-09-10       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.